← Evidence map

ArticleBrain pathology (Zurich, Switzerland)2013

MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3).

Kay Ka-Wai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

50 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23227829